Google
LH 株価分析 — Laboratory Corporation of America Holdings (Healthcare >> Diagnostics & Research)
LH に関するよくある質問
LHのPER（株価収益率）は？
Laboratory Corporation of America Holdings（LH）は現在PER 25.85倍で取引されています。
LHのROE（自己資本利益率）は？
Laboratory Corporation of America HoldingsのROEは10.79%です。
LHの配当利回りは？
Laboratory Corporation of America Holdingsの配当利回りは0.00%です。
LHの品質スコア（Quality Score）は？
当社のAIはLHの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
LHは今が買い時ですか？
当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
LHはどのセクターに属しますか？
Laboratory Corporation of America HoldingsはHealthcare >> Diagnostics & Researchセクターに分類されます（NYSE市場）
LH AI Analysis Summary
Our AI summary for LH: Laboratory Corporation of America Holdings (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 25.85, ROE of 10.79%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 309.20
Price
-6.33
(-2.01%)
Day Change
|
|
|---|
LH, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1843
|
| Magic Formula Rank by ROE |
1843
|
| Magic Formula Rank by ROIC |
2097
|
| Price | 309.20 |
| PBV / Sector |
2.78 / -29.69
|
| Earning Per Share | 11.96 |
| PE / Sector |
25.85 / 48.18
|
| PEG or PE/Growth / Sector |
2.05 / 1.64
|
| Average 1M Daily Value |
199.41 M
GREAT
|
| Average 1W Daily Value |
305.65 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:07 |
| Symbol | LH |
| Name | LABORATORY CORPORATION OF AMERICA HOLDINGS |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NYSE |
| Listed Shares | 82.00 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 24,335.14 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 358 South Main Street, Burlington, NC, United States, 27215
Phone: 336 229 1127
Website: https://www.labcorp.com
Employees: 71,000
Description: Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
